Abstract:Antibody microarrays permit the sensitive and semi‐quantitative analysis of the expression, covalent modification and interactions of proteins recovered from lysates of cells and tissues. At Kinexus, we have developed high content antibody microarrays that feature pan‐and phosphosite‐specific antibodies for tracking protein kinases, phosphatases and other low abundance cell signalling proteins for their expressions, covalent modifications and interactions with multiplex detection systems. KinexTM KAM antibody microarrays with 880 printed antibodies were used to monitor protein levels, phosphorylation and interactions with combinations of different detection systems. One method involved capture of in vitro dye‐labeled proteins (e.g. with Cy3) from lysates from cells subjected to diverse treatments. Another method involved the detection of general changes in their protein phosphorylation with biotinylated pIMAGO stain and an anti‐biotin antibody that is labeled with a different dye (e.g. Cy5). Alterations in protein‐tyrosine phosphorylation were monitored with a dye‐labelled, generic phosphotyrosine‐specific PYK rabbit polyclonal antibody in a sandwich antibody microarray (SAM) format. The SAM technique was also used to explore the interactions of adapter, scaffolding and chaperone proteins with hundreds of potential target signal transduction proteins with dye‐labeled reporter antibodies for these highly interactive proteins. We used several human cancer cell lines (e.g. A431, HeLa, Jurkat, MCF7) subjected to diverse treatments (e.g. growth factors) to identify biomarkers of the actions of these agents. Reproducible results were obtained with as little as 25 μg of lysate protein, with a dynamic range of detection exceeding 6000‐fold, and a median error range for duplicates measurements of ±12%. Typically 10–15% of the proteins tracked with these arrays demonstrate perturbations exceeding 50%. More than a third of the leads from our antibody microarrays were confirmed by immunoblotting studies. The major limitation associated with validation by Western blotting was the much lower sensitivity with immunoblotting compared with antibody microarrays. We also explored the specific interactions of heat shock proteins, adapter proteins, 14‐3‐3 and calcium‐binding proteins with the antibody microarray captured lysate proteins from cancer cell lines. By combining these detection strategies, it was feasible to obtain over 7000 measurements from use of a single antibody microarray slide. The goal of our proteomics and bioinformatics studies is to use the experimental results from the application of these microarrays to map the architecture of signaling networks in a cell‐ or tissue‐specific manner. Such multi‐tiered microarray‐based analyses permit target‐directed identification of diverse regulatory protein changes in different experimental model systems with greater sensitivity, breadth, selectivity and economy when compared to any other competing proteomics methodologies. Support or Funding Information Supported by Kinexus Bioinformatics Corporation.

Novel antibody microarray technologies for multiplex protein analysis in complex samples

A Cancer Protein Microarray Platform Using Antibody Fragments and Its Clinical Applications.

The Analysis of Antigen-antibody Interactions on Protein Microarrays

Antibody-microarrays on hybrid polymeric thin film-coated slides for multiple-protein immunoassays.

Methods and applications of antibody microarrays in cancer research

Protein and Antibody Microarrays and Their Biomedical Applications

Single-molecule immunoassay technology: Recent advances

Protein microarrays for studies of drug mechanisms and biomarker discovery in the era of systems biology.

Microdevices Integrating Affinity Columns and Capillary Electrophoresis for Multibiomarker Analysis in Human Serum

A Multiplexed Digital Platform Enables Detection of Attomolar Protein Levels with Minimal Cross-Reactivity

Protein microarrays and novel detection platforms

Ultrasensitive Ambient Mass Spectrometry Immunoassays: Multiplexed Detection of Proteins in Serum and on Cell Surfaces.

Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification

Two-color, Rolling-Circle Amplification on Antibody Microarrays for Sensitive, Multiplexed Serum-Protein Measurements.

Multiplex in Situ Tagging Technology for Highly Multiplexed Single-Cell Analysis

3-D microarray and its microfabrication-free fluidic immunoassay device

Parallel Detection and Quantification Using Nine Immunoassays in a Protein Microarray for Drug from Serum Samples

Detection of multiple proteins on one spot by laser ablation inductively coupled plasma mass spectrometry and application to immuno- microarray with element-tagged antibodies.

Profiling Signaling Protein Expression, Modifications and Interactions with Multi‐dimensional Antibody Microarrays

Graphically Encoded Suspension Array for Multiplex Immunoassay and Quantification of Autoimmune Biomarkers in Patient Sera.

Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers